Search

Your search keyword '"de Almeida Macedo, Maria Cristina Martins"' showing total 12 results
Start Over Author "de Almeida Macedo, Maria Cristina Martins"
12 results on '"de Almeida Macedo, Maria Cristina Martins"'

1. In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?

Author

Duarte, Fernando Barroso, primary, dos Santos Sousa, Talyta Ellen de Jesus, additional, Moreira Funke, Vaneuza Araujo, additional, Rensi Colturato, Virgílio Antônio, additional, Hamerschlak, Prof. Nelson, additional, Villela, Neysimelia, additional, de Almeida Macedo, Maria Cristina Martins, additional, Vigorito, Afonso Celso, additional, de Almeida Soares, Rodolfo Daniel, additional, Paz, Alessandra, additional, Diaz, Lilián, additional, Stevenazzi, Mariana, additional, Hallack Neto, Abrahão Elias, additional, Bettarello, Gustavo, additional, de Gusmão, Breno Moreno, additional, Salvino, Marco Aurélio, additional, Calixto, Rodolfo Froes, additional, Rodrigues Moreira, Maria Cláudia, additional, Teixeira, Gustavo Machado, additional, Silva, Cinthya Corrêa, additional, Paton, Eduardo, additional, Rocha, Vanderson, additional, Enrico, Alicia, additional, Bonfim, Carmem, additional, Chiattone, Ricardo Rabello, additional, Simioni, Anderson João, additional, Arrais, Celso, additional, and Coelho, Erika, additional

Published
2023
Full Text
View/download PDF

2. Impact of Treatment Prior to Allogeneic Transplantation of Hematopoietic Stem Cells in Patients with Myelodysplastic Syndrome: Results of the Latin American Bone Marrow Transplant Registry

Author

Duarte, Fernando Barroso, Moura, Anna Thawanny Gadelha, Funke, Vaneuza Araújo Moreira, Colturato, Virgílio Antônio Rensi, Hamerschlak, Nelson, Vilela, Neysimélia Costa, Lopes, Luiz Fernando, de Almeida Macedo, Maria Cristina Martins, Vigorito, Afonso Celso, de Almeida Soares, Rodolfo Daniel, Paz, Alessandra, Stevenazzi, Mariana, Diaz, Lilián, Neto, Abrahao Elias Hallack, Bettarello, Gustavo, de Gusmão, Breno Moreno, Salvino, Marco Aurélio, Calixto, Rodolfo Froes, Moreira, Maria Cláudia Rodrigues, Teixeira, Gustavo Machado, da Silva, Cinthya Corrêa, Simioni, Anderson João, and Lemes, Romélia Pinheiro Gonçalves

Published
2020
Full Text
View/download PDF

3. The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease

Author

Fernandes, Pedro Amoedo, primary, Russo, Flavia Tobaldini, additional, Monetta da Silva, Lucas Augusto, additional, Ferreira Ramos, Lafayete Willian, additional, Almeida Simões, Aline de, additional, Okada, Larissa Yukari, additional, Cavalcante, Jamilla Neves, additional, Ferreira Lopes, Maricy Almeida Viol, additional, De Almeida Macedo, Maria Cristina Martins, additional, and Da Silva, Roberto Luiz, additional

Published
2021
Full Text
View/download PDF

4. Changes in the Prevention and Treatment of GVHD over the Past Decade – Results of the Survey of the Brazil-Seattle Chronic GVHD Consortium

Author

Moreira Funke, Vaneuza Araujo, primary, Vigorito, Afonso Celso, additional, Rodrigues Moreira, Maria Cláudia, additional, Seber, Adriana, additional, Bonfim, Carmem, additional, Colturato, Vergilio A.R., additional, Souza, Mair Pedro, additional, Hamerschlak, Nelson, additional, Rocha, Vanderson, additional, Fatobene, Giancarlo, additional, Teixeira, Gustavo Machado, additional, Duarte, Fernando Barroso, additional, Paton, Eduardo, additional, Silla, Lucia, additional, Melo, Andresa, additional, de Almeida Macedo, Maria Cristina Martins, additional, Esteves, Iracema, additional, Coelho, Erika, additional, Navarro Barros, George Mauricio, additional, Chiattone, Ricardo Rabello, additional, Novis, Yana, additional, Lerner, Decio, additional, da Silva, Roberto Luiz, additional, Pasquini, Ricardo, additional, and Flowers, Mary E.D., additional

Published
2021
Full Text
View/download PDF

5. Chronic GVHD Treatment in Brazil: Analyses of Failure Free Survival

Author

Vigorito, Afonso Celso, primary, Miranda, Eliana C M, additional, Colturato, Vergilio A.R., additional, Simioni, Anderson João, additional, Funke, Vaneuza, additional, Neves, Heliz Regina A., additional, de Almeida Macedo, Maria Cristina Martins, additional, da Silva Santos Geraldo, Bruna Letícia, additional, Ribeiro, Lorena Bedotti, additional, da Silva, Paula Moreira, additional, Fatobene, Giancarlo, additional, Daudt, Liane Esteves, additional, de Oliveira da Silva, Priscila, additional, Rodrigues Moreira, Maria Cláudia, additional, Lermontov, Simone Pereira, additional, Barbosa Mariano, Livia Caroline, additional, Rocha, Vanderson, additional, Colella, Marcos Paulo, additional, Guzelotto, Larissa Codogno, additional, Rodrigues, Morgani, additional, da Silva, Cinthya Corrêa, additional, Hamerschlak, Nelson, additional, Chiattone, Ricardo Rabello, additional, and Flowers, Mary E.D., additional

Published
2021
Full Text
View/download PDF

6. 403 - In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?

Author

Duarte, Fernando Barroso, dos Santos Sousa, Talyta Ellen de Jesus, Moreira Funke, Vaneuza Araujo, Rensi Colturato, Virgílio Antônio, Hamerschlak, Prof. Nelson, Villela, Neysimelia, de Almeida Macedo, Maria Cristina Martins, Vigorito, Afonso Celso, de Almeida Soares, Rodolfo Daniel, Paz, Alessandra, Diaz, Lilián, Stevenazzi, Mariana, Hallack Neto, Abrahão Elias, Bettarello, Gustavo, de Gusmão, Breno Moreno, Salvino, Marco Aurélio, Calixto, Rodolfo Froes, Rodrigues Moreira, Maria Cláudia, Teixeira, Gustavo Machado, Silva, Cinthya Corrêa, Paton, Eduardo, Rocha, Vanderson, Enrico, Alicia, Bonfim, Carmem, Chiattone, Ricardo Rabello, Simioni, Anderson João, Arrais, Celso, and Coelho, Erika

Published
2023
Full Text
View/download PDF

7. Influence of the Cell Source and Conditioning System on Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome.

Author

Duarte, Fernando Barroso, primary, Moura, Anna Thawanny Gadelha, additional, Funke, Vaneuza Araújo Moreira, additional, Colturato, Virgílio Antônio Rensi, additional, Hamerschlak, Nelson, additional, Vilela, Neysimélia Costa, additional, Lopes, Luiz Fernando, additional, de Almeida Macedo, Maria Cristina Martins, additional, Vigorito, Afonso Celso, additional, de Almeida Soares, Rodolfo Daniel, additional, Paz, Alessandra, additional, Stevenazzi, Mariana, additional, Diaz, Lilián, additional, Neto, Abrahao Elias Hallack, additional, Bettarello, Gustavo, additional, de Gusmão, Breno Moreno, additional, Salvino, Marco Aurélio, additional, Calixto, Rodolfo Froes, additional, Moreira, Maria Cláudia Rodrigues, additional, Teixeira, Gustavo Machado, additional, da Silva, Cinthya Corrêa, additional, Simioni, Anderson João, additional, and Lemes, Romélia Pinheiro Gonçalves, additional

Published
2020
Full Text
View/download PDF

8. Challenges and Strategies of a Brazilian Transplant Center (TC) to Report Data on Stem Cell Transplantation (HCT) in an International Database: Experience Report

Author

da Silva Santos Geraldo, Bruna Letícia, primary, Tanabe, Regina Harumi, additional, do Nascimento Varjão, Vanessa Aparecida, additional, Minari, Denise Borges Rego, additional, de Souza, Miriam Nascimento, additional, Monetta, Lina, additional, de Almeida Macedo, Maria Cristina Martins, additional, and da Silva, Roberto Luiz, additional

Published
2019
Full Text
View/download PDF

9. 339 - Changes in the Prevention and Treatment of GVHD over the Past Decade – Results of the Survey of the Brazil-Seattle Chronic GVHD Consortium

Author

Moreira Funke, Vaneuza Araujo, Vigorito, Afonso Celso, Rodrigues Moreira, Maria Cláudia, Seber, Adriana, Bonfim, Carmem, Colturato, Vergilio A.R., Sr., Souza, Mair Pedro, Hamerschlak, Nelson, Rocha, Vanderson, Fatobene, Giancarlo, Teixeira, Gustavo Machado, Duarte, Fernando Barroso, Paton, Eduardo, Silla, Lucia, Melo, Andresa, de Almeida Macedo, Maria Cristina Martins, Esteves, Iracema, Coelho, Erika, Navarro Barros, George Mauricio, Chiattone, Ricardo Rabello, Novis, Yana, Lerner, Decio, da Silva, Roberto Luiz, Pasquini, Ricardo, and Flowers, Mary E.D.

Published
2021
Full Text
View/download PDF

10. 301 - Chronic GVHD Treatment in Brazil: Analyses of Failure Free Survival

Author

Vigorito, Afonso Celso, Miranda, Eliana C M, Colturato, Vergilio A.R., Sr., Simioni, Anderson João, Funke, Vaneuza, Neves, Heliz Regina A., de Almeida Macedo, Maria Cristina Martins, da Silva Santos Geraldo, Bruna Letícia, Ribeiro, Lorena Bedotti, da Silva, Paula Moreira, Fatobene, Giancarlo, Daudt, Liane Esteves, de Oliveira da Silva, Priscila, Rodrigues Moreira, Maria Cláudia, Lermontov, Simone Pereira, Barbosa Mariano, Livia Caroline, Rocha, Vanderson, Colella, Marcos Paulo, Guzelotto, Larissa Codogno, Rodrigues, Morgani, da Silva, Cinthya Corrêa, Hamerschlak, Nelson, Chiattone, Ricardo Rabello, and Flowers, Mary E.D.

Published
2021
Full Text
View/download PDF

11. Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols.

Author

Tobaldini Russo, Flávia, de Almeida Macedo, Maria Cristina Martins, Amoedo Fernades, Pedro, Okada, Larissa Yukari, da Silva, Lucas Augusto Monetta, Menin Simões, Camila, Cavalcante, Jamilla Neves, de Almeida Simões, Aline, de Souza Sampaio Almeida, Manuella, Ferreira Lopes, Maricy Almeida Viol, and da Silva, Roberto Luiz

Subjects
*LYMPHOCYTIC leukemia, *ACUTE leukemia, *BORTEZOMIB, *LYMPHOBLASTIC leukemia
Abstract

Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment. Until this moment, there is no gold standard therapy for the treatment of adult patients with acute relapsed/refractory lymphoblastic leukemia. In this case report, we describe two cases of relapsed leukemia: one of lymphocytic leukemia B and one of trilineage leukemia, which presented a satisfactory response to treatment with Bortezomib associated with Vincristine, Dexamethasone, and Bendamustine. [ABSTRACT FROM AUTHOR]

Published
2020

12. Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil.

Author

Pereira J, Bellesso M, Pracchia LF, Neto AE, Beitler B, de Almeida Macedo MC, Dias LC, Dorlhiac-Llacer PE, Dulley FL, and Chamone D

Subjects
Adolescent, Adult, Brazil, Cytarabine administration & dosage, Developing Countries, Disease-Free Survival, Etoposide administration & dosage, Female, Humans, Ifosfamide administration & dosage, Male, Middle Aged, Recurrence, Transplantation, Autologous, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Lymphoma, B-Cell prevention & control, Lymphoma, Non-Hodgkin prevention & control, Stem Cell Transplantation
Abstract

Background: The purpose of this retrospective study was to investigate the efficacy, toxicity and mobilization rate after modified Magrath IVAC (mIVAC) chemotherapy regimen prescribed in relapsed disease (RD) or primary refractory disease (PRD) in aggressive non-Hodgkin lymphoma (NHL)., Patients and Methods: Twenty-four patients (16 males, 8 females) aged 18-59 years (median age 37 year) were analyzed. The most frequent histopathological subgroup was diffuse large B-cell lymphoma (DLCL-B) (n=21/24), 13 (54%) were considered RD and 11 (46%) PRD. The mIVAC consisted of ifosfamide (IFM), high dose cytarabine and etoposide repeated every 28 days., Results: The overall response (OR) after three cycles of mIVAC was 66. 6%. Among the patients with PRD, OR was 45.5% (5 out of 11) and with RD was 86.4%, p>0.05, however, it was observed in RD better complete response (CR) than PRD 53.8x9.1% (p<0.05). Eighty-eight percent (14 out of 16) of patients with chemosensitive disease to mIVAC underwent autologous stem cell transplantation (ASCT). The median number of collected CD34+ cells was 2.86x10(6) (range 2.17x10(6) to 4.9x10(6)). The median overall survival rate (OS) for chemosensitive to mIVAC was 16.3 months, with a median follow-up of 16 months. Grades III-IV neutropenia was observed in 85.6% per cycles and grades III-IV thrombocytopenia in 87.5%. Grades III-IV febrile neutropenia was the most common nonhematological toxicity, it occurred in 28% of the cycles and no deaths by toxicity were observed., Discussion: Although a statistic comparative study was not carried out for these 24 patients, the rate of OR to mIVAC was alike the other second-line infusion regimens. The mobilization failure rate was 57.1% and it was similar to other regimens with high dose cytarabine, but it did not limit performed ASCT.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results